Intravenous (IV) Solutions Market With Focus On Growth Analysis, Production, Consumption, Revenue, Analysis By 2027

Comments · 34 Views

Intravenous (IV) Solutions Market is projected to register a CAGR of 7.69% By 2023. Intravenous (IV) Solutions Market Type, Application | Intravenous (IV) Solutions Industry

Intravenous (IV) Solutions Market: Information by Nutrition Type (Peripheral Parenteral Nutrition and Total Parenteral Nutrition), Bag Type (Large Volume Bags and Small Volume Bags), Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins Minerals, Parenteral Lipid Emulsion), End User (Hospitals clinics, Ambulatory Surgical Centers and Home Care) - Forecast till 2028

Market Synopsis:

The advancements in the healthcare sector are inducing growth in the markets that offer medical products. Intravenous systems form a crucial part of medical treatments and surgeries. It is expected to witness high demand over the next couple of years. A study, offered by Market Research Future (MRFR), has found out that the global Intravenous (IV) Solution market is expected to register a CAGR of 7.69% across the projection period 2016 to 2022. The assessment also asserts that the market is anticipated to scale a valuation of USD 11,511.2 Mn by the end of 2022.

IV solutions are extensively used for treatments ranging from fluid deficiency to cancer diagnosis. The rising burden of chronic diseases is likely to propel the expansion of Intravenous (IV) Solution market in the years to come. The demand for IV solution is huge and signifies opportunities for innovations. Many companies are leveraging packaged intravenous fluids with sterile water for administration to patients. It has already garnered a considerable share of the Intravenous (IV) Solution market and is likely to witness an upswing in demand in the foreseeable future.

The healthcare sector is observing a boom and is expected to thrive further over the assessment period. This, in turn, is anticipated to propel the expansion of the Intravenous (IV) Solution market in the upcoming years. In addition, it has been projected that the rising adoption of vitamin C intravenous treatment therapy for the treatment of colorectal cancer will unleash developmental opportunities for the market players.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1235

Market Segmentation:

By type, the global Intravenous (IV) Solution market has been bifurcated into total parenteral solution, peripheral parenteral solution. Among these, the total parenteral solution segment was valued at USD 4,940.0 Mn in 2016 and is expected to hold the dominant share of the market over the assessment period.

Based on nutritional content, the Intravenous (IV) solution market has been segmented into carbohydrates, amino acid solution, vitamins minerals, parenteral lipid emulsion, and others. The amino acid solution segment, which stood at a valuation of USD 2,385 Mn in 2016, is expected to retain its pole position through the review period.

By end user, the global Intravenous (IV) solution market has been segmented into hospitals clinics, ambulatory, and home care.

Regional Analysis:

The global Intravenous (IV) solution market, by region, has been segmented into North America, Europe, Asia Pacific, and the Middle East Africa (MEA). North America held the leading position in the global marketplace in 2015. It is forecasted to retain its forefront position over the review period. The rising prevalence of cancer in conjunction with high consumption of IV solution is poised to fuel the growth of the Intravenous (IV) Solution market in the forthcoming years.

Asia Pacific is expected to scale the highest CAGR of 8.34% between 2016 and 2022. The developments in the healthcare sector of the region backed by increasing healthcare expenditure are anticipated to augment the Intravenous (IV) solution market over the next couple of years.

Competitive Dashboard:

The key players of the Intravenous (IV) Solution market profiled in this MRFR report are ICU Medical, Inc. (U.S.), Fresenius Kabi AG (Germany), B. Braun Melsungen AG (Germany), Baxter (U.S.), Terumo Medical Corporation (Tokyo), Amanta Healthcare (India), and Grifols S.A. (Spain).

Industry News:

In May 2019, B. Braun Medical, a German medical and pharmaceutical device company, has announced its investment of USD 1 Bn in into new and existing IV fluid manufacturing facilities for alleviating he IV solution shortage.

In May 2019, Phebra, an Australian pharmaceutical firm, has initiated its international business expansion with the inauguration of its subsidiary entity in Canada, namely Phebra Canada.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/intravenous-solution-market-1235 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments